Live Analyst Rating Changes 37946 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Steve Frankel
ROSE

Steve Frankel

Rosenblatt Securities
Wall Street Analyst
★★☆☆☆
#2676
on 13Foresight · ranked by our own returns
46%
Success Rate
-1.8%
Average Return
17 of 37 calls profitable · +22.1% vs benchmark
S&P 500 (SPY)
📈 Across the calls we could measure, roughly 46% of Steve Frankel's ratings turned a profit when each position was held for 1 year — averaging -1.8% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

37 Buy 2 Hold 0 Sell
Steve's Stock Coverage 18 ratings · 2026-10-06
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return vs S&P 500 ⓘ
IMAX
IMAX
 Sep 28, 2026 BUY Strong Buy
-25.4% avg upside
22 analysts
 — -9.0% ·
HLIT
Harmonic
 Sep 16, 2026 BUY Buy
+18.5% avg upside
14 analysts
$20.00
78.34% Upside
 +0.6% ·
DLB
Dolby Laboratories
 Aug 27, 2026 BUY Buy
+37.4% avg upside
7 analysts
$85.00
43.19% Upside
 -5.6% ·
LINC
Lincoln Edu
 Aug 10, 2026 BUY Strong Buy
+76.9% avg upside
7 analysts
$50.00
125.31% Upside
 -28.0% ·
UEIC
Universal Electronics
 Aug 06, 2026 HOLD Hold
+382.8% avg upside
3 analysts
$5.00
8.86% Downside
 +21.4% ·
XPER
Xperi Inc
 Aug 06, 2026 BUY Strong Buy
+107.1% avg upside
4 analysts
$10.00
84.09% Upside
 -23.0% ·
UTI
Universal Technical Institute
 Aug 06, 2026 BUY Strong Buy
+92.6% avg upside
8 analysts
$45.00
134.74% Upside
 -30.2% ·
SONO
Sonos
 Jul 29, 2026 BUY Buy
+15.9% avg upside
10 analysts
$21.00
17.01% Upside
 -0.5% ·
ADEA
Adeia
 Jun 12, 2023 BUY Strong Buy
+20.4% avg upside
11 analysts
$15.00
42.40% Downside
 +10.9% ·
GAIA
Gaia
 Mar 01, 2022 BUY Strong Buy
+535.1% avg upside
6 analysts
$12.00
757.11% Upside
 -50.9% ·
SEAC
SeaChange International
 Dec 23, 2021 HOLD Strong Buy
+136.2% avg upside
5 analysts
 — -74.9% ·
DHC
Diversified Healthcare Trust
 Apr 28, 2021 HOLD Hold
+46.6% avg upside
11 analysts
$5.00
33.62% Downside
 -47.5% ·
IRT
Independence Realty
 Apr 28, 2021 BUY Strong Buy
+32.5% avg upside
24 analysts
$19.00
29.15% Upside
 +68.3% ·
MPT
Medical Properties Trust
 Apr 28, 2021 BUY Hold
+268.4% avg upside
24 analysts
$25.00
655.31% Upside
 -12.1% ·
CPT
Camden Property
 Apr 28, 2021 BUY Buy
+22.3% avg upside
32 analysts
$134.00
37.57% Upside
 +39.6% ·
MAA
MAA
 Apr 28, 2021 HOLD Buy
+27.3% avg upside
39 analysts
$170.00
45.88% Upside
 +36.7% ·
CHCT
Community Healthcare
 Apr 28, 2021 HOLD Strong Buy
+153.8% avg upside
12 analysts
$52.00
289.27% Upside
 -22.5% ·
NFLX
Netflix
 Jan 13, 2017 HOLD Strong Buy
+148.7% avg upside
80 analysts
 — +65.5% ·
🔒 13 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Steve Frankel — Frequently Asked Questions
How accurate are Steve Frankel's stock ratings?
Based on the calls 13Foresight could measure, about 46% of Steve's ratings were profitable over a one-year hold, with an average return of -1.7% per rating, or +22.2% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Steve ranked on 13Foresight?
Steve Frankel is currently ranked #2676 with a 2-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Steve cover?
Steve most recently has ratings on IMAX, HLIT, DLB, LINC, UEIC, XPER, UTI, SONO, ADEA, GAIA, SEAC, DHC and 6 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.